Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma

被引:140
|
作者
Zhang, Hongwei [1 ]
Li, Mengbin [1 ]
Han, Yu [2 ]
Hong, Liu [1 ]
Gong, Taiqian [1 ]
Sun, Li [1 ]
Zheng, Xiushan [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Prov, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol, Xian 710032, Shaanxi Prov, Peoples R China
关键词
miR-27a; Multidrug resistance; Apoptosis; Esophageal squamous cell carcinoma; GASTRIC ADENOCARCINOMA; MICRORNA EXPRESSION; LEUKEMIA; BCL-2; PROGRESSION; METASTASIS; APOPTOSIS; PROGNOSIS; PATHWAYS;
D O I
10.1007/s10620-009-1051-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background So far, the miRNAs involved in multidrug resistance of esophageal cancer have not been reported. Aims and Methods Here we have firstly investigated the roles of miR-27a in multidrug resistance of esophageal squamous cell carcinoma using MTT assay, flow cytometry assay, and reporter gene assay, etc. Results Down-regulation of miR-27a could confer sensitivity of both P-glycoprotein-related and P-glycoprotein-non-related drugs on esophageal cancer cells, and might promote ADR-induced apoptosis, accompanied by increased accumulation and decreased releasing amount of ADR. Down-regulation of miR-27a could significantly decrease the expression of P-glycoprotein, Bcl-2, and the transcription of the multidrug resistance gene 1, but up-regulate the expression of Bax. Conclusions MiR-27a might play important roles in multidrug resistance of esophageal cancer. The further study of the biological functions of miR-27a might be helpful for developing possible strategies to treat esophageal cancer.
引用
收藏
页码:2545 / 2551
页数:7
相关论文
共 50 条
  • [1] Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
    Hongwei Zhang
    Mengbin Li
    Yu Han
    Liu Hong
    Taiqian Gong
    Li Sun
    Xiushan Zheng
    Digestive Diseases and Sciences, 2010, 55 : 2545 - 2551
  • [2] Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
    Xiaohong Zhao
    Li Yang
    Jianguo Hu
    Journal of Experimental & Clinical Cancer Research, 30
  • [3] Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
    Zhao, Xiaohong
    Yang, Li
    Hu, Jianguo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [4] Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1
    Huang, Xiao-Ping
    Li, Xuan
    Situ, Min-Yi
    Huang, Li-Yun
    Wang, Jun-Ye
    He, Tian-Cheng
    Yan, Qi-Hang
    Xie, Xiu-Ying
    Zhang, Yu-Jing
    Gao, Yuan-Hong
    Li, Yu-Hong
    Rong, Tie-Hua
    Wang, Ming-Rong
    Cai, Qing-Qing
    Fu, Jian-Hua
    CANCER LETTERS, 2018, 414 : 294 - 300
  • [5] Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma
    Maghsudlu, Mohaddese
    Farashahi Yazd, Ehsan
    Amiriani, Taghi
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (01) : 227 - 233
  • [6] Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma
    Mohaddese Maghsudlu
    Ehsan Farashahi Yazd
    Taghi Amiriani
    Journal of Gastrointestinal Cancer, 2020, 51 : 227 - 233
  • [7] Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma
    Cui-Qi Zhou Shuang Liu Yi-Hua Wang Hong-Xia Zhu Ning-Zhi Xu Laboratory of Cell and Molecular Biology
    World Journal of Gastroenterology, 2003, 9 (09) : 1900 - 1903
  • [8] Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma
    Zhou, CQ
    Liu, S
    Xue, LY
    Wang, YH
    Zhu, HX
    Lu, N
    Xu, NZ
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (09) : 1900 - 1903
  • [9] Telomerase activity in esophageal squamous cell carcinoma: Down-regulation by chemotherapeutic agent
    Mitsui, A
    Kuwabara, Y
    Iwase, H
    Mitani, M
    Shinoda, N
    Sato, A
    Toyama, T
    Sugiura, M
    Suzuki, T
    Kato, J
    Fujii, Y
    JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) : 37 - 45
  • [10] Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma
    Kudo, Y
    Kitajima, S
    Ogawa, I
    Miyauchi, M
    Takata, T
    ORAL ONCOLOGY, 2005, 41 (02) : 105 - 116